Skip to main content
Premium Trial:

Request an Annual Quote

OpGen to Offer Qiagen Nucleic Acid Purification Tech With Acuitas Pathogen Panel

NEW YORK (GenomeWeb) — OpGen said today that it has signed an agreement to offer Qiagen nucleic acid purification technology with its Acuitas antimicrobial resistance detection panel.

Under the terms of the deal, Gaithersburg, Maryland-based OpGen will purchase Qiagen's EZ1 Advanced XL automated nucleic acid purification instruments and reagent kits, which enable automated sample preparation throughput of up to 14 samples per one-hour run. OpGen will offer the EZ1 products to its US customers for use with its research-use-only Acuitas AMR Gene Panel u5.47 for the detection of multidrug-resistant bacterial pathogens in urine or bacterial isolates.

Additional terms were not disclosed.

"The EZ1 provides best in class nucleic acid purification technology, and Qiagen's extensive global commercial capabilities and diagnostic expertise should provide multiple opportunities for collaboration in the future," OpGen CEO Evan Jones said in a statement.

This week, Hilden, Germany-based Qiagen reported third quarter revenue growth of 4 percent amid growth in sales of both consumables and instrumentation. OpGen, meanwhile, recently priced a $3.2 million stock offering in order to raise funds to continue developing the Acuitas panel and companion Lighthouse software.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.